Objective: Infected aortofemoral grafts pose a formidable challenge with a significant risk of limb loss and high mortality. Despite successful reports of obturator canal bypass (OCB) for infected aortofemoral graft and complicated groins, the technique has not gained widespread use. We reviewed our experience with OCB and performed a systematic review of the literature.
The management of an infected graft still poses a formidable clinical challenge and carries with it a significant morbidity in terms of limb loss and high mortality rate of up to 25%.
1-3 Shaw and Baue originally described the technique of obturator bypass as an operation to allow perfusion to the distal extremity through clean uninvolved planes. 4 Since then, the use of obturator bypass has expanded to encompass the infected femoral artery (including through intravenous drug abuse), the hostile femoral reoperation, and the irradiated field. [5] [6] [7] [8] [9] [10] [11] [12] [13] Despite successful reports of use of the obturator bypass for aortobifemoral bypass graft infections and complicated femoral infections, the technique has not gained widespread use and is often overlooked in favor of other extra-anatomic options for revascularization, such as axillary-femoral or popliteal bypass grafting and autologous bypasses, such as the neoaortoiliac system (NAIS) bypass. Published series of obturator bypass, performed for various indications, report primary patency rates as low as 25% and as high as 100% at 12 months [14] [15] [16] and lack longer term follow-up data, with little information on limb loss rates and adjunctive procedures. The small number of published cases and lack of adequate long-term follow-up with respect to obturator bypass have been previously commented on by Blaisdell 17 ; attempts to better define the outcome after obturator bypass have been undertaken, with the most recent of these published two decades ago. 18 This study reports the long-term outcomes associated with obturator bypass at a single center during an 18-year period.
METHODS
Patients and procedures. Patients were retrospectively identified, and chart review was performed to include only patients who had undergone bypass through the obturator foramen between 1995 and 2013. The study analysis ended at 2013 to allow follow-up at 2 years to be completed in all patients. Bilateral obturator foramen bypasses were treated as separate and distinct limbs with respect to patency and limb salvage. The study identified 18 obturator bypasses in 15 patients. Follow-up was performed at 1 month, 3 months, and 6 months, then yearly thereafter unless more frequent follow-up was identified from clinical need. Ankle-brachial indices were obtained at each visit; contrasted computed tomography (CT) scan was pursued on an individualized basis.
Technique of obturator canal bypass (OCB). The technique of OCB is described briefly here and has been previously reported. 18, 19 Transperitoneal standard inframesocolic exposure to the infrarenal aorta and graft body when necessary or retroperitoneal exposure of a single graft limb or iliac artery is obtained, depending on the CT imaging. Obturator bypass is considered in situations in which infection is confined to the groin, and appropriateness of this approach is confirmed at the time of operation with documentation of the absence of fluid or phlegmon and good graft incorporation before transection of the involved graft limb and advancement distally into the retroperitoneal tunnel. In cases in which graft body infection or suprainguinal evidence of infection of the graft limbs is suspected on the basis of CT imaging, total graft explantation with use of in situ repair with cryopreserved graft, deep femoral vein, or occasionally rifampin-soaked polytetrafluoroethylene (PTFE) graft is performed if the patient is an appropriate operative candidate. An opening in the ventromedial aspect of the obturator membrane is created, usually by palpating the pubis and moving laterally until the tough obturator membrane is felt. The tunnel is created mainly by feel as visualization of this region is usually impossible. Scissors can be used to incise the membrane over finger guidance to allow the blunt-tipped tunneling device to traverse the membrane into the thigh. Standard aboveknee popliteal or distal superficial femoral artery exposure is prepared. An expanded PTFE (ePTFE) 8 mm Â 80 cm graft (W. L. Gore & Associates, Phoenix, Ariz) is tunneled through the obturator membrane between the proximal inflow source and distal artery (Fig 1) . Systemic anticoagulation is given, and the proximal inflow source (graft body, graft limb, or native aorta or iliac artery) is prepared and anastomosed to the ePTFE graft. The distal anastomosis is then performed in a standard end-to-side manner. These incisions are then closed and covered with sterile occlusive dressings before attention is turned to the groin. All prosthetic material is removed with oversewing of the common femoral artery and débride-ment of infected tissue with preservation of the femoral bifurcation, if possible. In rare cases in which the bifurcation cannot be salvaged, brisk backbleeding is sought as a clinical indication to the adequacy of internal iliac collaterals and guides the decision about the need for transposition or direct profunda revascularization. Tissue coverage is then managed with the use of vacuumassisted closure or a muscle flap, depending on local conditions in the groin wound.
Definitions. The Society for Vascular Surgery reporting standards for peripheral artery disease were adhered to for standardized reporting of postoperative outcomes. 20 Stenosis is broadly defined as narrowing of the arterial lumen and is termed significant when it is >70%. Restenosis is defined as a narrowing of the arterial lumen that recurs after endovascular or open procedures. Primary patency refers to patency that is obtained without the need for additional or secondary surgical or endovascular procedures or the interval from the time of the original intervention until any intervention designed to maintain or to re-establish patency is performed. Primary assisted patency is patency of the intervention achieved with the use of an additional or secondary surgical or endovascular procedure, as long as occlusion of the primary treated site has not occurred. Secondary patency is patency obtained with the use of an additional or secondary surgical or endovascular procedure after occlusion occurs. Major adverse cardiac events include myocardial infarction, stroke, and death. Major adverse limb events include major reintervention and below-knee or above-knee amputation.
Statistical analysis. Deidentified data were analyzed through a database using SPSS 17 for Windows (SPSS Inc, Chicago, Ill). Descriptive statistics such as mean and standard deviation were applied where appropriate. The Kaplan-Meier method was used to estimate survival and patency rates. Comparison of similar effects and outcomes was sought, wherever possible, to decrease data heterogeneity. Weighted averages of percentage outcomes were computed, following arcsine transformation with weights based on the variance of the effect size.
ARTICLE HIGHLIGHTS d
Type of Research: Retrospective single-center study d Take Home Message: Eighteen polytetrafluoroethylene obturator bypasses resulted in a 2-year secondary patency of 88% and a 3-year limb salvage of 81%. There were three amputations, and one graft was removed because of infection.
The authors suggest that obturator bypass can be performed with few severe complications in patients with infected aortofemoral graft, and long-term results are good in those with one-sided femoral artery infections.
RESULTS
Characteristics of the patients. During the study period, a total of 15 patients (18 limbs) were operated on. Three patients underwent bilateral obturator bypasses. The majority of patients who underwent OCB were male (73%), and the left limb of a previously placed aortobifemoral bypass graft was most often operated on (67%). The mean age of patients was 59.6 6 12 years (range, 22-71). Demographics, comorbidities, and surgical indication are summarized in Table I . Infection was the most common indication for OCB in 12 limbs (67%), with Staphylococcus the most frequent organism cultured during the perioperative period alongside Pseudomonas, Streptococcus, and Corynebacterium. Table II summarizes the pertinent patient-specific information for the 15 patients treated with OCB. Most patients had undergone a previous aortobifemoral bypass (10 patients; 67%) before OCB. The majority of OCBs were performed with inflow from either the existing graft body or graft limb (10 limbs; 56%), with 4 limbs from the aorta (22%) and 4 limbs from the native iliac arteries (22%). The above-knee popliteal artery was the most commonly chosen outflow artery (14 limbs; 78%), with the distal superficial femoral artery in 4 limbs (22%). Sixteen of the 18 original operations (89%) were performed for occlusive disease, with 2 limbs (11%) presenting with previous aneurysm repairs (1 endovascular aneurysm repair and 1 open aneurysm repair). The mean duration of surgery was 380 6 115 minutes (range, 246-572), with mean length of stay of 11 6 5.5 days (range, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] .
Early outcomes (within 30 days). There were no major adverse cardiac events or major adverse limb events within 30 days. There were three superficial wound infections, with one patient requiring a return to the operating room for hematoma evacuation. Two patients suffered other complications, one deep venous thrombosis and one gastrointestinal bleed.
Midterm outcomes. Mean follow-up for the patient cohort was 57.7 6 42.3 months (range, 7.4-181). During the study period, there was one myocardial infarction (6%), with five late deaths at a mean duration of 51.2 months after OCB (33%). Regarding major adverse limb events, three limbs (17%) underwent above-knee amputation, with another procedure needed for 11 of the 18 limbs (61%). One of these three amputations occurred 7 months after OCB because of an infected ankle joint from orthopedic hardware placed 1 month before the OCB. The second occurred at 40 months and the third at 15 months after OCB, with both related to ischemia at the time of OCB graft thrombosis. Open reoperations to the OCB were graft thrombectomy in two limbs (11%), revision to the distal anastomosis in two limbs (11%), and a femorofemoral bypass graft in one limb (6%). Hybrid open and endovascular procedures occurred in two limbs (11%), and catheter-directed thrombolysis to the OCB occurred in four limbs (22%). These interventions are detailed in Table III . The mean time was 42 months to first reoperation and 35 months to first reintervention after the obturator bypass operation. One obturator graft was found to be infected at late follow-up, requiring removal at 42 months after the initial operation (6%).
Primary patency was determined using Kaplan-Meier analysis and was 65% at 24 months (Fig 2, a) ; primary assisted patency was 71% at 24 months (Fig 2, b) . Secondary patency of OCB at 24 months was 88% (Fig 3) . Overall survival was 83% and overall limb salvage was 81% at 36 months (Fig 4) .
DISCUSSION
Aortic graft infection still remains a challenge in contemporary vascular surgery, with mortality and amputation rates that are significant. There are numerous reports of aortic graft infection treated with removal of the aortic graft and replacement with antibiotic-soaked prosthetic, cryopreserved in situ replacement, femoropopliteal NAIS bypass, or extraanatomic bypass, and the optimal strategy is still a controversial topic. [21] [22] [23] [24] [25] Infections isolated to a single femoral anastomosis or graft limb present an interesting clinical conundrum and have led to innovative strategies for aortic graft preservation with excision of the affected graft limb only. 26, 27 The treatment principles for management of any vascular infection should be adhered to, irrespective of the mode of treatment. Targeted antibiotic therapy, control of sepsis, and CT imaging form the preoperative management of vascular graft infections. After initial stabilization, a clean revascularization procedure is performed if it is clinically warranted using a rifampinsoaked ePTFE conduit. The obturator bypass is then isolated with sterile occlusive dressings, followed by removal of all infected material and débridement of tissues back to healthy planes. This strategy has been successfully employed at our institution when infection is clinically, radiographically, and intraoperatively confined to one groin and distal graft limb. In this series, there was one case of obturator bypass infection in a complex patient who had previously undergone a thoracobipopliteal bypass for multiple aortic operations; successive thrombectomies ultimately led to graft reinfection. No other patients suffered from OCB infection or required excision of the remainder of the prosthetic aortobifemoral bypass. Crawford et al described a similar experience with management of unilateral graft limb infections with excision of the affected graft without total graft explantation. 26 The authors' approach to revascularization in the 15 described patients was by femoral-femoral bypass in 10 patients, axillary-femoral bypass in 3 patients, and inline revascularization in 2 patients. Conduits included autogenous femoral vein, PTFE graft, cryopreserved femoral vein, and paneled reversed saphenous vein. The authors concluded that approximately 50% of patients undergoing unilateral graft limb excision developed main graft body or contralateral limb infection at a median of 2 years. They further analyzed these patients and described a 71% positive predictive value for contralateral limb or graft body infection for patients with evidence of suprainguinal graft infection with a corresponding 75% negative predictive value for further graft infection confined to the infrainguinal portion of the graft. Although the rates of contralateral or graft body infection are much higher than in our series, the approaches are significantly different, with revascularization far removed from the site of infection (proximal graft to distal superficial femoral artery/popliteal artery) through a nonviolated surgical plane, the obturator foramen. In addition, any intraoperative evidence of suprainguinal graft infection at the time of exploration of the proximal anastomosis site led to abandonment of the obturator bypass, and an alternative means of revascularization was sought. Calligaro et al described a small series of patients who underwent complete or partial graft preservation for documented aortic graft body infections in patients at high risk for operation. 28 The authors described various approaches to management of these graft infections, including percutaneous or operative drainage, instillation of antibiotics into the drains three times daily with repeated débridement of infected groin wounds, and long-term intravenous antibiotic therapy. The authors detailed seven of the nine patients who survived hospitalization at mean follow-up of 7.6 years without recurrent infection, with only one above-knee amputation and two deaths in the series. Whereas we fully agree with the conclusions drawn by Calligaro et al that this is a strategy contrary to conventional concepts, it does lend argument to the broader clinical possibility of a less invasive means of treating limited unilateral graft infections, especially in cases in which a limited retroperitoneal rather than midline transperitoneal incision can be used for access for the proximal OCB graft anastomosis. The long-term patency of any treatment strategy for aortic graft infection is an important clinical consideration as the mean age of the patients in our series was relatively young, and therefore there exists a reasonable expectation of longevity for the patient. The obturator bypass is a relatively long prosthetic bypass to the distal superficial femoral artery or popliteal artery, with the majority of patients treated for pre-existing obstructive disease, and just more than half of patients treated underwent an open operation or endovascular procedure to maintain or to re-establish OCB patency during the follow-up period. This highlights a need for long-term follow-up of this complex problem as many of the operations and procedures were performed at a mean of at least 3 years from the initial obturator bypass operation. Clagett et al described the largest series of NAIS procedures for infected aortic grafts with longterm follow-up of 7 years. 25 The authors described overall mortality of around 10% and morbidity from early amputation in 7.4%, with fasciotomy performed for venous hypertension in 12%. Despite these relatively significant outcomes, the authors do describe excellent primary patency of 81% at 7-year follow-up with 91% assisted primary patency during the same period. Although their series involves replacement of the infected aortic graft with autologous tissue in a bilateral fashion rather than a more limited unilateral excision, any discussion of operations for infected aortic grafts should be moderated by consideration of the long-term patency that can be achieved with use of the deep vein conduit as described by Clagett et al.
CONCLUSIONS
The OCB can be performed safely with minimal early morbidity and mortality in well-selected patients with infections limited to one femoral anastomosis site. Limb salvage and overall mortality in this series are excellent and in agreement with the reported literature on OCB. Long-term follow-up is recommended because of a significant reoperation and reintervention rate. 
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